The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets.
Bodovitz
Steven
S
Select Biosciences, 2040 Hyde Street, San Francisco, CA 94109, USA. bodovitz@selectbiosciences.com
Joos
Thomas
T
D015415:Biomarkers / Q000032:analysis*; D016503:Drug Delivery Systems / Q000379:methods*; D015195:Drug Design; D004345:Drug Industry / Q000379:methods / Q000639:trends; D010449:Peptide Mapping / Q000379:methods*; D004364:Pharmaceutical Preparations / Q000032:analysis*; D025941:Protein Interaction Mapping / Q000379:methods; D020543:Proteome / Q000032:analysis*; D040901:Proteomics / Q000379:methods* / Q000639:trends; D011786:Quality Control; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D015415:Biomarkers; D004364:Pharmaceutical Preparations; D020543:Proteome